Prof. Maria Cecilia Giron Appointed President of ISM, Pioneering Microbiota Research
The scientific Board announce the appointment of Prof. Maria Cecilia Giron as the President of the International Society of Microbiota (ISM). This appointment marks a significant milestone in her illustrious career and promises to be a turning point in the field of microbiota research.
Dr. Giron has an extensive and impressive background in the field of pharmacology and clinical studies. Her invaluable contributions are evident through her roles in various prestigious committees, including the Ethics Committee for Clinical Studies at Padova University Hospital, the Ethics Committee for Oncological Clinical Trials at the Veneto Institute of Oncology, and the Veneto Region Medicines Evaluation Committee.
A true pioneer in her field, Dr. Giron's research has been instrumental in shedding light on the intricate relationship between gut microbiota and intestinal function in both normal and pathological conditions. Her dedication to advancing our understanding of microbiota's role in human health is underscored by her impressive portfolio of over 60 peer-reviewed publications.
Furthermore, Dr. Giron's commitment to pushing the boundaries of microbiota research extends beyond academia. She is a co-founder of Eubiome, an innovative university spin-off and startup, dedicated to exploring the therapeutic applications of gut microbiota in both human and animal recipients, as well as pioneering research in the field of fecal microbiota transplantation (FMT).
Under her leadership, we anticipate that ISM will continue to flourish and lead the way in microbiota research, forging new paths and fostering collaboration to uncover the profound implications of microbiota in health and disease. We congratulate Prof. Maria Cecilia Giron on this remarkable achievement and eagerly await the exciting developments she will bring to the forefront of microbiota research.
